Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease (Q46117950)
Jump to navigation
Jump to search
scientific article published on 19 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease |
scientific article published on 19 February 2009 |
Statements
1 reference
Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease (English)
1 reference
Hideyo Sugahara
1 reference
Chiharu Maebara
1 reference
Hisakazu Ohtani
1 reference
Masanori Handa
1 reference
Katsumi Ando
1 reference
Kazunori Mine
1 reference
Chiharu Kubo
1 reference
Ichiro Ieiri
1 reference
Yasufumi Sawada
1 reference
19 February 2009
1 reference
65
1 reference
7
1 reference
699-704
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference